Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-05-07
1986-07-08
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514211, 514255, 514520, 514650, A61U 3155, A61U 31135, A61U 31275, A61U 31435, A61U 31495
Patent
active
045993408
ABSTRACT:
A method for reducing soft tissue flap necrosis in a patient undergoing reconstructive surgery is disclosed. The method comprises administering to such patient an effective amount of a calcium channel blocking drug or a pharmaceutically acceptable non-toxic salt thereof to reduce said necrosis of said flap. Also disclosed are pharmaceutical compositions suitable for use in reducing soft tissue flap necrosis.
REFERENCES:
Chem. Abst. 98--119164v (1983).
Goldenberg Barry
Silver Lester
Friedman Stanley J.
Gray Edward P.
Miles Laboratories Inc.
LandOfFree
Enhanced soft tissue flap survival in reconstructive surgery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced soft tissue flap survival in reconstructive surgery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced soft tissue flap survival in reconstructive surgery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1451299